
|Articles|November 15, 2003
Laser system yields high rate of patient satisfaction in study
Author(s)Lynda Charters
Rochester, NY-The Technolas 217 Z Zyoptix Personalized Vision Correction system (Bausch & Lomb) was approved by the FDA for use in the United States last month (see related news on Page 1). About 99% of patients expressed extreme satisfaction or satisfaction with the visual results afforded them by the system, which may increase patient interest in refractive surgery.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages
2
Detecting peripheral retinal lesions in children with myopia
3
FDA grants priority review to Satralizumab sBLA for thyroid eye disease
4
4DMT completes enrollment in 4FRONT-2, global phase 3 trial of 4D-150 in wet AMD
5


























